Expertise in
1
conditions

Hans G. Van Der Hoeven-Van Der Voet

Godesberger Allee 64, 
Bonn, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Godesberger Allee 64, 
Bonn, NW, DE 

Overview

Hans Van Der Hoeven-Van Der Voet practices practicing medicine in Bonn, Germany.

Mr. Van Der Hoeven-Van Der Voet is highly rated in 1 condition, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), Cardiac Arrest, Pancreaticoduodenectomy, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 71 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Godesberger Allee 64, Bonn, NW 53175, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

MONITOR-IC: a Mixed Methods Multicenter Prospective Open Cohort Study Determining and Improving Long-term Outcomes of ICU Survivors
MONITOR-IC: a Mixed Methods Multicenter Prospective Open Cohort Study Determining and Improving Long-term Outcomes of ICU Survivors
Enrollment Status: Recruiting
Publish Date: December 27, 2023
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis
The Eshre Study Into The Evaluation of Oocyte Euploidy by Microarray Analysis
Enrollment Status: Completed
Publish Date: January 16, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trial

70 Total Publications

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.
Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.
Journal: European urology
Published: December 23, 2025

Frequently Asked Questions about Hans G. Van Der Hoeven-Van Der Voet

Is Hans G. Van Der Hoeven-Van Der Voet a top-rated expert for COVID-19?

MediFind is an objective health platform that identifies experts based on real-world data. Hans G. Van Der Hoeven-Van Der Voet is classified as an Advanced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hans G. Van Der Hoeven-Van Der Voet participate in research or clinical trials?

Yes. Hans G. Van Der Hoeven-Van Der Voet has published 70 articles and abstracts on conditions like COVID-19. You can view a list of Hans G. Van Der Hoeven-Van Der Voet's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Van Der Hoeven-Van Der Voet's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile